preeclampsia - Nursing Case Study
Pathophysiology
• Primary mechanism: Abnormal placentation leads to poor remodeling of uterine spiral arteries, causing high resistance and reduced blood flow to the placenta. This results in placental ischemia and release of factors that damage endothelial cells.
• Secondary mechanism: Endothelial dysfunction triggers a systemic inflammatory response, increasing vascular permeability and vasoconstriction. This elevates blood pressure and contributes to widespread organ damage.
• Key complication: Endothelial injury and hypertension may lead to multi-organ damage, notably affecting the kidneys (proteinuria), liver (elevated liver enzymes), and brain (seizures), escalating the condition to severe preeclampsia or eclampsia.
Patient Profile
Demographics:
30-year-old female, school teacher
History:
• Key past medical history: Gestational hypertension in a previous pregnancy
• Current medications: Prenatal vitamins, labetalol
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and visual disturbances
• Key symptoms: Swelling in hands and feet, upper abdominal pain, nausea
• Vital signs: Blood pressure 160/110 mmHg, heart rate 95 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
As the healthcare team continues to monitor the patient, her condition evolves with concerning developments. Initial assessment findings reveal significant proteinuria, with a urine protein-to-creatinine ratio of 0.35, suggesting worsening renal impairment. Her liver function tests show elevated levels of AST and ALT, indicative of hepatic involvement, with AST at 85 U/L and ALT at 90 U/L. These findings are consistent with the progression towards severe preeclampsia. The patient's blood pressure remains elevated despite her current medication regimen, maintaining a range around 162/112 mmHg. The persistent hypertension, along with her neurological symptoms of headache and visual disturbances, raises the clinical suspicion of potential cerebral involvement.
The care team decides to perform a non-stress test to assess fetal well-being, given the risk of placental insufficiency. The test reveals a reactive pattern, which is reassuring for the time being, but the patient's clinical status demands close observation. Magnesium sulfate is initiated to prevent the development of eclampsia, considering her neurological symptoms and rising blood pressure. This intervention requires diligent monitoring of the patient's reflexes and respiratory status to mitigate the risk of magnesium toxicity.
In light of these developments, the healthcare team discusses the possibility of expedited delivery, weighing the risks of continued maternal deterioration against the gestational age of the fetus. The decision will require comprehensive clinical reasoning, incorporating the patient's current status, potential for further complications, and the need for neonatal considerations. This stage of the patient's journey underscores the dynamic nature of preeclampsia management, as the team strives to stabilize her condition while planning for a safe delivery.
Section 2
As the healthcare team continues to monitor the patient, her condition begins to exhibit new complications. Despite the initiation of magnesium sulfate, the patient reports an intensifying headache and an increase in visual disturbances, raising immediate concerns of impending eclampsia. Her neurological examination reveals hyperreflexia, and her patellar reflexes are brisk, suggesting she is nearing the threshold of magnesium toxicity. Additionally, her respiratory rate has decreased to 10 breaths per minute, prompting the team to reassess her magnesium levels, which are found to be elevated at 9 mg/dL. This requires an urgent adjustment of her magnesium infusion rate to prevent further respiratory depression.
Concurrently, further diagnostic results reveal worsening hepatic function with an increase in AST and ALT to 105 U/L and 120 U/L, respectively, indicating progression towards HELLP syndrome. Her platelet count has also dropped to 95,000/mm³, confirming the suspicion of hematological complications. The patient's blood pressure remains inadequately controlled, fluctuating between 168/114 mmHg and 172/116 mmHg, despite escalating doses of antihypertensive medications. These developments necessitate a more aggressive management plan, as the risk of maternal and fetal compromise escalates.
Given these critical changes, the healthcare team urgently convenes to discuss the feasibility of an expedited delivery. The patient is currently at 33 weeks' gestation, which poses significant challenges for neonatal outcomes. However, the worsening maternal condition, coupled with the potential for rapid decompensation, underscores the need for immediate intervention. The team must weigh the benefits of prolonging the pregnancy for fetal maturity against the immediate risks to the mother's health, making a decision that will be pivotal to both maternal and fetal safety.
Section 3
As the healthcare team grapples with the complexities of the patient's condition, they decide to prioritize a comprehensive reassessment of her current status. The patient's vital signs reveal a further decline in her respiratory function, with a rate now reduced to 8 breaths per minute, despite the adjustment in her magnesium sulfate infusion. This respiratory depression necessitates immediate intervention, prompting the team to administer calcium gluconate to counteract the magnesium toxicity and stabilize her breathing. The patient's oxygen saturation has dropped to 88%, and supplemental oxygen is initiated to prevent hypoxia. Her hypertensive state remains unyielding, with blood pressure readings persistently elevated at 170/112 mmHg, raising concerns about the potential for cerebrovascular accidents.
In light of these developments, the team conducts an urgent ultrasound to assess fetal well-being. The results indicate signs of fetal distress, characterized by a decreased biophysical profile score and reduced amniotic fluid index, signaling placental insufficiency. This finding, coupled with the maternal instability, strengthens the argument for an expedited delivery. The team discusses the use of corticosteroids to enhance fetal lung maturity, recognizing the critical balance between maternal stabilization and neonatal outcomes.
The patient's neurological status remains precarious, with ongoing headaches and visual disturbances, suggesting a deteriorating pre-eclamptic state. Her altered hepatic function and dropping platelet count continue to signal the progression towards full-blown HELLP syndrome, necessitating vigilant monitoring and potential transfusion considerations. As the healthcare team deliberates on the timing and mode of delivery, they must navigate these challenges with precision, ensuring that both maternal and fetal safety are optimized in this rapidly evolving clinical scenario.
Section 4
The patient's response to the administered calcium gluconate shows a gradual improvement in her respiratory status, with her breathing rate increasing to 12 breaths per minute. However, her oxygen saturation remains concerning at 90% despite continuous supplemental oxygen, indicating ongoing respiratory compromise. A blood gas analysis reveals a mixed respiratory and metabolic acidosis, with pH 7.32, PaCO2 48 mmHg, and HCO3- 20 mEq/L, necessitating further interventions to optimize her respiratory function and acid-base balance. The team decides to initiate non-invasive positive pressure ventilation (NIPPV) to enhance alveolar ventilation and improve oxygenation, aiming to stabilize her respiratory status further.
Concurrently, the patient's laboratory results reveal a worsening trend in her hepatic and hematological profiles. Her liver enzymes have risen sharply, with AST at 250 U/L and ALT at 280 U/L, while her platelet count has plummeted to 75,000/µL, confirming the progression towards HELLP syndrome. This alarming development prompts the team to expedite the administration of corticosteroids to accelerate fetal lung maturity, while also preparing for the potential need for platelet transfusions to manage her coagulopathy. The patient's persistently elevated blood pressure, now at 172/114 mmHg, continues to pose a significant risk for intracranial hemorrhage, prompting the team to escalate antihypertensive therapy with intravenous labetalol to achieve better control.
Amidst these critical changes, the decision is made to proceed with an emergency cesarean section. The deteriorating maternal condition, coupled with fetal distress and placental insufficiency, leaves little room for delay. As the surgical team prepares, the healthcare team remains vigilant, closely monitoring the patient's neurological status and vital signs, ready to address any intraoperative or postoperative complications that may arise. The urgency of delivering the baby is weighed against the necessity of maintaining maternal hemodynamic stability, underscoring the complexity and gravity of the situation at hand.
Section 5
As the surgical team prepares for the emergency cesarean section, the patient experiences a sudden change in status that necessitates immediate attention. Her neurological assessments indicate an acute onset of confusion and disorientation, suggesting potential cerebral involvement due to the severe hypertension. Her pupillary reflexes are sluggish, and she exhibits mild clonus, raising concerns for impending eclampsia. The healthcare team quickly administers a bolus of intravenous magnesium sulfate to prevent seizure activity, while continuing to monitor her closely for any further neurological deterioration.
In the operating room, the anesthesiology team evaluates the best method for anesthesia, taking into account the patient's coagulation status and potential risks associated with spinal or epidural anesthesia. Due to the significant thrombocytopenia and the risk of bleeding complications, they opt for general anesthesia for the safety of both mother and baby. Throughout the procedure, the obstetric and surgical teams work in tandem, balancing the urgency of delivery with the need to maintain the patient's hemodynamic stability. Her blood pressure remains high despite the ongoing labetalol infusion, emphasizing the critical nature of the situation.
The cesarean section proceeds with a heightened sense of urgency as fetal heart rate monitoring indicates persistent decelerations, suggestive of compromised fetal oxygenation. The baby is delivered swiftly and transferred to the neonatal team for immediate resuscitation and care. Meanwhile, the surgical team focuses on managing the mother's bleeding, given the increased risk due to her low platelet count. Post-operatively, the patient is transferred to the intensive care unit for continuous monitoring and stabilization, while the focus shifts to managing her multi-system complications and ensuring her recovery. The healthcare team remains vigilant, anticipating possible postpartum hemorrhage and other potential complications, while also coordinating with neonatologists to support the newborn's transition and health.